C
Christopher S. McKee
Researcher at Newcastle University
Publications - 4
Citations - 278
Christopher S. McKee is an academic researcher from Newcastle University. The author has contributed to research in topics: Autophagy & Apoptosis. The author has an hindex of 4, co-authored 4 publications receiving 219 citations.
Papers
More filters
Journal ArticleDOI
Exploiting Cannabinoid-Induced Cytotoxic Autophagy to Drive Melanoma Cell Death
Jane L. Armstrong,Jane L. Armstrong,D. S. Hill,Christopher S. McKee,Sonia Hernández-Tiedra,Mar Lorente,Israel López-Valero,M.E. Anagnostou,Fiyinfoluwa Babatunde,Marco Corazzari,Christopher P.F. Redfern,Guillermo Velasco,Penny E. Lovat +12 more
TL;DR: It is suggested that THC activates noncanonical autophagy-mediated apoptosis of melanoma cells, suggesting that cytotoxic autophile induction with Sativex warrants clinical evaluation for metastatic disease.
Journal ArticleDOI
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization.
Sonia Hernández-Tiedra,Gemma Fabriàs,David Dávila,Íñigo J. Salanueva,Josefina Casas,L-Ruth Montes,Zuriñe Antón,Elena García-Taboada,María Salazar-Roa,Mar Lorente,Jesper Nylandsted,Jane L. Armstrong,Israel López-Valero,Christopher S. McKee,Ana Serrano-Puebla,R García-López,José González-Martínez,José Luis Abad,Kentaro Hanada,Patricia Boya,Félix M. Goñi,Manuel Guzmán,Penny E. Lovat,Marja Jäättelä,Alicia Alonso,Guillermo Velasco +25 more
TL;DR: It is shown that THC (but not nutrient deprivation) increases the dihydroceramide:ceramide ratio in the endoplasmic reticulum of glioma cells, and this alteration is directed to autophagosomes and autolysosomes to promote lysosomal membrane permeabilization, cathepsin release and the subsequent activation of apoptotic cell death.
Journal ArticleDOI
Oncogenic BRAF signalling increases Mcl-1 expression in cutaneous metastatic melanoma.
TL;DR: It is suggested that the regulation of Mcl‐1 expression by BRAF signalling is increased by oncogenic activation of BRAF, revealing a mechanism of apoptotic resistance which may be overcome by the use of more specifically targeted M cl‐1 inhibitors.
Journal ArticleDOI
Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase/AKT signalling and autophagy.
T J Wright,Christopher S. McKee,Mark A. Birch-Machin,Robert Ellis,Jane L. Armstrong,Penny E. Lovat +5 more
TL;DR: Combined AKT inhibition and chloroquine treatment of MET 4 cSCC cells resulted in significantly enhanced inhibition of cell viability and apoptosis induced by clinically achievable concentrations of docetaxel (P < 0.001), indicating that inhibition of both autophagy and AKT represents an effective and viable therapeutic strategy to increase the cytotoxicity ofDocetaxe for the treatment of advanced cS CC.